Stock Updates

A look at a High Market Cap Stock: Abbott Laboratories, ABT

Abbott Laboratories, ABT is in the exchange NYSE and its industry is Medical Appliances & Equipment in the sector of Healthcare. Based in USA, Abbott Laboratories, ABT  has a market cap of 63631.71. Since its IPO date on the 4/6/1983, Abbott Laboratories, ABT performance year to date is -2.08%. Today Abbott Laboratories, ABT has gained 0.97%, with a current price of 43.59.

Ownership of the company is 0.30% for insider ownership while institutional ownership is 73.90%. The management of the company have seen the company have a payout ratio of 66.50%. Return of assets are at 5.60%, with return on investment at 7.70%.

In terms of debt levels and profit levels, Abbott Laboratories, ABT is seeing a long-term debt/equity of 0.29. While Total debt/equity is 0.41. With a profit margin of 11.10%, this is combined with a gross margin of 56.90%, and operating margin of 14.00%. Abbott Laboratories ability to meet debt levels, with a current ratio of 1.5, while the quick ratio is 1.2.

For the last year Abbott Laboratories, ABT has seen a EPS growth of 53.50%. A performance for the year of 3.11%. The 52-week high is -4.80%, and the 52-week low is 22.57%. The average volume for Abbott Laboratories, ABT is 25644528.

With a target price of 48, can Abbott Laboratories, ABT reach this target? Looking at the value indicators of Abbott Laboratories, ABT. Abbott Laboratories has a P/E of 33.13 and a forward P/E of 17.55. Perhaps the more useful indicator than P/E, is PEG which has a value of 3.54. Abbott Laboratories also has a P/S and a P/B of 3.1 and 3.08 respectively. For P/cash, Abbott Laboratories has a value of 14.34, while it is 315.01 for P/free cash flow.

At the current price of 43.59, Abbott Laboratories has a dividend yield of 2.41%. We see a return on equity of 10.90%.

Looking more long-term Abbott Laboratories, is projected to get an EPS growth for the next five years of 9.36%. In the short-term an EPS growth of 11.82% in the next year is forecasted. This is after a EPS growth of 53.50% for this year and for the last five years a -10.30% growth has been seen.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Stephen Butters

Leave a Comment